Rein Therapeutics, Inc. (RNTX)
Nasdaq: RNTX · Pharmaceutical Preparations · Austin, TX · filing with the SEC since 2007
Filings
306 filings since 2017 beside 209 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026Due nextNon-accelerated filer and smaller reporting company
10-Q
Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end.
by Nov 14, 2026
10-K
Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends.
by Mar 31, 2027
A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Jun 8, 2026.
Filings a yearinsider forms included
7055403819745031
2026 counts to Nov 13, 2026.
Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Aug 27, 2026.Officer or director change (8-K item 5.02): 7 times in the last 36 months, the newest Feb 19, 2026.Auditor change (8-K item 4.01): 2 times in the last 36 months, the newest Apr 17, 2025.SEC letters: 9 in the last 36 months, the newest Apr 28, 2026.A late-filing notice, Form NT 10-K, filed Mar 31, 2025.A late-filing notice, Form NT 10-K, filed Apr 1, 2024.
Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.
FiledFormWhat it is, in plain wordsPeriodAsk
May 4, 2026
8-K items 1.01, 8.01, 9.01
Major agreement signed; Other event · Current report
Apr 30, 2026
Mar 2, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Feb 24, 2026
Jan 16, 2026
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Jan 15, 2026
Oct 24, 2025
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Oct 23, 2025
Sep 9, 2025
8-K items 1.01, 2.03, 3.02, 9.01
Major agreement signed; New debt or obligation taken on; Shares sold without registration · Current report
Sep 8, 2025
40 of 306 shown
Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.